Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific anti...
Apr 27, 2025, 2:00 PM EDT - 7 weeks ago
Mar 25, 2025, 4:30 PM EDT - 2 months ago
Mar 10, 2025, 6:34 PM EDT - 3 months ago
Dec 12, 2024, 4:05 PM EST - 6 months ago